Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $16.98M.
ENTERPRISE VALUE (EV)
$16.98M
Dyadic International, Inc.
Market Cap
$16.58M
Enterprise Value (EV)
$16.98M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Dyadic International, Inc. (DYAI) | $16.58M | $16.98M |
| BioCardia, Inc. (BCDA)vs › | $16.27M | $12.44M |
| Bionano Genomics, Inc. (BNGO)vs › | $16.81M | $19.78M |
| PAVmed Inc. (PAVM)vs › | $16.85M | $30.14M |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.75M | $21.06M |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.17M | $5.84M |
| Lipocine Inc. (LPCN)vs › | $17.19M | $12.21M |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.58M | $14.75M |
| Cosmos Health Inc. (COSM)vs › | $17.34M | $31.52M |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.15M | N/A |
Market Cap
$16.58M
Total Debt
$5.03M
Cash
$4.62M
Enterprise Value
$16.98M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
